Metsera outlines $250M IPO plans as obesity biotech competition rises

Metsera, a well-funded biotech trying to angle toward the front of the obesity medicine pack, has proposed a $250 million IPO.

That would be the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Trump’s CMS freeze, and the Cole Schmidtknecht lawsuit

This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here. Welcome back, everyone. Glad you

January 27, 2025

Novartis enters deal for Arvinas’ prostate cancer therapy

Share this article Novartis will be responsible for the development and commercialisation of ARV-766. Credit: Taljat David / Shutterstock.com. Novartis has signed an exclusive strategic

April 12, 2024

SK Life spotlights epilepsy awareness efforts like Uber rides, mentor program and more on ‘Purple Day’

SK Life Science celebrated annual “Purple Day” for epilepsy awareness on Tuesday with a new mentoring program and a recommitment to its ongoing Uber ride-sharing

March 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.